Abstract
■ Conjunctival melanoma is very rare, but occurs more frequently in white than in black individuals
■ Conjunctival melanoma often occurs in the setting of primary acquired melanosis (PAM) with atypia and is less often associated with a conjunctival nevus
■ Conjunctival melanoma shares many clinical, epidemiological and molecular features with cutaneous but not uveal melanoma
■ It is plausible that the presence of clinically atypical nevus of the skin (particularly when in a familial setting and in association with cutaneous melanoma) is etiologically linked to conjunctival melanoma
■ There is substantial evidence implicating ultraviolet radiation (UVR) as inducing conjunctival melanoma, probably through the mitogen-activated protein kinase pathway
■ Because conjunctival melanoma occasionally arises in parts of the conjunctiva protected from UVR exposure, alternative pathways may exist
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman AB, Sood R, Koenig M (1991) Primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol 4:253–263
Akor C, Greenberg MF, Pollard ZF, Grossniklaus HE (2004) Conjunctival melanoma in a child. J Pediatr Ophthalmol Strabismus 41:56–58
Aoyagi M, Morishima N, Yoshino Y, et al. (1993) Conjunctival malignant melanoma with xeroderma pigmentosum. Ophthalmologica 206:162–167
Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3:395–401
Augustsson A, Stierner U, Suurküla M, Rosdahl I (1991) Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 124:152–156
Bataille V, Boyle J, Hungerford JL, Newton JA (1993) Three cases of primary acquired melanosis of the conjunctiva as a manifestation of the atypical mole syndrome. Br J Dermatol 128:86–90
Bataille V, Pinney E, Hungerford JL, et al. (1993) Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol 129:198–201
Bataille V, Sasieni P, Cuzick J, et al. (1995) Risk of ocular melanoma in relation to cutaneous and iris nevi. Int J Cancer 60:622–626
Belkin PV (1975) Malignant melanoma of the bulbar conjunctiva in a dog. Vet Med Small Anim Clin 70:957–958
Bergman L, Seregard S, Nilsson B, et al. (2002) Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 43:2579–2583
Betharia SM, Vashisht S, Kalra BR (1985) Malignant melanoma of conjunctiva following surgical excision of naevus. Indian J Ophthalmol 33:259–261
Betton A, Healy LN, English RV, Bunch SE (1999) Atypical limbal melanoma in a cat. J Vet Intern Med 13:379–381
Brownstein S, Faraji H, Jackson WB, Font RL (2006) Conjunctival melanoma in children: a clinicopathologic study of 2 cases. Arch Ophthalmol 124:1190–1193
Buckman G, Jakobiec FA, Folberg R, McNally LM (1988) Melanocytic nevi of the palpebral conjunctiva. An extremely rare location usually signifying melanoma. Ophthalmology 95:1053–1057
Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1664–1678
Charles NC, Stenson S, Taterka HB (1979) Epibulbar malignant melanoma in a black patient. Arch Ophthalmol 97:316–318
Chau KY, Hui SP, Cheng GP (1999) Conjunctival melanotic lesions in Chinese: comparison with Caucasian series. Pathology 31:199–201
Chowers I, Livni N, Frucht-Pery J, Pe’er J (1999) Immunostaining of the estrogen receptor in conjunctival primary acquired melanosis. Ophthalmic Res 31:210–212
Colby KA, Nagel DS (2005) Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman. Cornea 24:352–355
Cook CS, Rosenkrantz W, Peiffer RL, MacMillan A (1985) Malignant melanoma of the conjunctiva in a cat. J Am Vet Med Assoc 186:505–506
Dalrymple J (1852) Pathology of the human eye. Churchill, London
Davies H, Bignell GR, Cox C, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Daxecker F, Philipp W, Mikuz G, Lisch K (1988) Late manifestations of conjunctival malignant melanoma. Ophthalmologica 197:176–178
Demirci H, Shields CL, Shields JA, Eagle RC Jr (2000) Malignant melanoma arising from unusual conjunctival blue nevus. Arch Ophthalmol 118:1581–1584
Donaldson D, Sansom J, Scase T, et al. (2006) Canine limbal melanoma: 30 cases (1992–2004). I. Signalment, clinical and histological features and pedigree analysis. Vet Ophthalmol 9:115–119
Edwards RH, Ward MR, Wu H, et al. (2004) Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 41:270–272
El-Shabrawi Y, Radner H, Muellner K, et al. (1999) The role of UV-radiation in the development of conjunctival malignant melanoma. Acta Ophthalmol Scand 77:31–32
Folberg R, McLean IW, Zimmerman LE (1985) Primary acquired melanosis of the conjunctiva. Hum Pathol 16:129–135
Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T (1989) Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology 96:436–461
Folberg R, Jakobiec FA, McLean IW, Zimmerman LE (1992) Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ. Mod Pathol 5:2–5
Foss AJ, Alexander RA, Guille MJ, et al. (1995) Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology 102:431–435
Friedman RJ, Rodriguez-Sains R, Jakobiec F (1987) Ophthalmologic oncology: conjunctival malignant melanoma in association with sporadic dysplastic nevus syndrome. J Dermatol Surg Oncol 13:31–34
Gear H, Williams H, Kemp EG, Roberts F (2004) BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci 45:2484–2488
Gerner N, Norregaard JC, Jensen OA, Prause JU (1996) Conjunctival naevi in Denmark 1960–1980. A 21-year follow-up study. Acta Ophthalmol Scand 74:334–337
Gloor P, Alexandrakis G (1995) Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci 36:1721–1729
Goldenberg-Cohen N, Cohen Y, Rosenbaum E, et al. (2005) T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci 46:3027–3030
Gwosdz C, Schekenbach K, Lieven O, et al. (2006) Comprehensive analysis of the p53 status in mucosal and cutaneous melanoma. Int J Cancer 118:577–582
Hada Y, Onishi K, Yokoyama D, Inoe M (1995) Two cases of conjunctival malignant melanoma. Jpn J Clin Ophthalmol 49:919–922
Henkind P, Friedman AH (1971) External ocular pigmentation. Int Ophthalmol Clin 11:87–111
Hicks C, Liu C, Hiranandani M, et al. (1994) Conjunctival melanoma after excision of a lentigo maligna melanoma in the ipsilateral eyelid skin. Br J Ophthalmol 78:317–318
Hu DN (2005) Photobiology of ocular melanocytes and melanoma (2005) Photochem Photobiol 81:506–509
Inskip PD, Devesa SS, Fraumeni JF Jr (2003) Trends in the incidence of ocular melanoma in the United States, 1974–1998. Cancer Causes Control 14:251–257
Isager P, Osterlind A, Engholm G, et al. (2005) Uveal and conjunctival malignant melanoma in Denmark, 1943–97: incidence and validation study. Ophthalmic Epidemiol 12:223–232
Iwamoto S, Burrows RC, Grossniklaus HE, et al. (2002) Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol 120:1625–1629
Jakobiec FA, Zuckerman BD, Berlin AJ, et al. (1985) Unusual melanocytic nevi of the conjunctiva. Am J Ophthalmol 100:100–113
Jensen OA (1962) Xeroderma pigmentosum observed in a Greenlander. Report of a case complicated by malignant melanoma of the conjunctiva. Acta Ophthalmol (Copenh) 40:96–103
Kraemer KH, Greene MH, Tarone R, et al. (1983) Dysplastic naevi and cutaneous melanoma risk. Lancet 2:1076–1077
Lederman M (1961) Radiotherapy of malignant melanomata of the eye. Br J Radiol 43:21–42
Lee SB, Au Eong KG, Saw SM, et al. (2000) Eye cancer incidence in Singapore. Br J Ophthalmol 84:767–770
Levene A (1973) Precancerous and cancerous melanosis of the canine conjunctiva. J Comp Pathol 83:253–257
Li L, Hu DN, Zhao H, et al. (2006) Uveal melanocytes do not respond to or express receptors for alpha-melanocyte stimulating hormone. Invest Ophthalmol Vis Sci 47:4507–4512
MacKenzie W (1835) A Practical treatise on the diseases of the eye, 3rd edn. Longman, Rees, Orme, Brown, Green and Longmans, London
Maldonado JL, Fridlyand J, Patel H, et al. (2003) Determinants of BRAF mutations in primary melanoma. J Natl Cancer Inst 95:1878–1880
McCowan C, Stanley RG (2004) Pigmented squamous cell carcinoma of the conjunctiva of a horse. Vet Ophthalmol 7:421–423
McDonnell JM, Carpenter JD, Jacobs P, et al. (1989) Conjunctival melanocytic lesions in children. Ophthalmology 96:986–993
McDonnell JM, Mayr AJ, Martin WJ (1989) DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med. 320:1442–1446
McLaughlin CC, Wu X-C, Jemal A, et al. (2005) Incidence of noncutaneous melanoma in the U.S. Cancer 103:1000–1007
Mehta C, Gupta CN, Krishnaswamy M (1996) Malignant melanoma of conjunctiva with xeroderma pigmentosa – a case report. Indian J Ophthalmol 44:165–166
Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355:51–65
Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D (2005) Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 46:75–82
Newell GR, Sider JG, Bergfelt L, Kripke ML (1988) Incidence of cutaneous melanoma in the United States by histology with special reference to the face 4:5036–5041
Norregaard JC, Gerner N, Jensen OA, Prause JU (1996) Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 234:569–572
Oosterhuis JA, Went LN, Bergman W (1991) Ocular melanoma associated with the familial mole melanoma syndrome (FAMM). In: Lynch HT, Fusaro RM (eds) Hereditary malignant melanoma. CRC, Boca Raton
Paridaens AD, McCartney AC, Hungerford JL (1992) Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum. Br J Ophthalmol 76:120–122
Parkin DM, Whelan SL, Ferlay J, et al. (2002) Cancer incidence in 5 continents, vol VIII. IARC, Lyon
Poynter JN, Elder JT, Fuller DR, et al. (2006) BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 16:267–273
Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U (1993) Malignant melanoma of the vulva and vagina. Trends in incidence, age-distribution, and long-term survival in 245 consecutive cases in Sweden 1960-1984. Cancer 71:1893–1897
Ragnarsson-Olding B, Platz A, Olding L, Ringborg U (2004) p53 protein expression and TP53 mutations in malignant melanoma of sun-sheltered mucosal membranes versus chronically sun exposed skin. Melanoma Res 14:395–401
Reese AB (1938) Precancerous melanosis and diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol 19:354–365
Robertson DM, Hungerford JL, McCartney A (1989) Pigmentation of the eyelid margin accompanying conjunctival melanoma. Am J Ophthalmol 108:435–439
Rodriguez-Sains RS (1986) Ocular findings in patients with the dysplastic nevus syndrome. Ophthalmology 93:661–665
Saida T, Kawachi S, Takata M, et al. (2004) Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis. Pathology 36:404–413
Sakai H, Yanai T, Kawakami S, Masegi T (2001) Malignant melanoma of the palpebral conjunctiva in a captive fallow deer. J Wildl Dis 37:816–819
Scotto J, Fraumeni JF Jr, Lee JA (1976) Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 56:489–491
Seregard S (1993) Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am J Ophthalmol 116:93–97
Seregard S (1996) Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma. J Clin Pathol 49:338–342
Seregard S (1998) Conjunctival melanoma. Surv Ophthalmol 42:321–350
Seregard S (2000) Pigmented spindle cell naevus of Reed presenting in the conjunctiva. Acta Ophthalmol Scand 78:104–106
Seregard S, Kock E (1992) Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol (Copenh) 70:289–296
Seregard S, af Trampe E, Månsson-Brahme E, Kock E, Bergenmar M, Ringborg U (1995) Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology 102:1524–1529
Seregard S, Oskarsson M, Spangberg B (1999) Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions. Exp Eye Res 69:671–676
Shields CL, Fasiuddin AF, Mashayekhi A, Shields JA (2004) Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol 122:167–175
Singh AD, Campos OE, Rhatigan RM, Schulman JA, Misra RP (1998) Conjunctival melanoma in the black population. Surv Ophthalmol 43:127–133
Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J (2004) Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49:419–428
Spendlove HE, Damato BE, Humphreys J, Barker KT, Hiscott PS, Houlston RS (2004) BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res 14:449–452
Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD (2005) Increasing incidence of lentigo melanoma subtypes: Northern California and national trends 1990–2000. J Invest Dermatol 125(4):685–691
Takehara A, Dake Y, Amemiya T (1995) Treatment of malignant melanoma of conjunctiva. Jpn J Clin Ophthalmol 49:431–434
Tannous ZS, Lerner LH, Duncan LM, Mihm MC Jr, Flotte TJ (2000) Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type. Hum Pathol 31:705–708
To KW, Rabinowitz SM, Friedman AH, Merker C, Cavanaugh CP (1989) Neurofibromatosis and neural crest neoplasms: primary acquired melanosis and malignant melanoma of the conjunctiva. Surv Ophthalmol 33:373–379
Toth-Molnar E, Olah J, Dobozy A, Hammer H (2004) Ocular pigmented findings in patients with dysplastic naevus syndrome. Melanoma Res 14:43–47
Travers B (1820) A synopsis of the diseases of the eye and their treatment. Longman, Hurst, Rees, Orme & Brown, London
Tuomaala S, Kivela T (2003) Conjunctival melanoma: is it increasing in the United States. Am J Ophthalmol 136:1189–1190
Tuomaala S, Eskelin S, Tarkkanen A, Kivela T (2002) Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 43:3399–3408
Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken JF, Giles GG, Armstrong BK (2004) Artificial ultraviolet radiation and ocular melanoma in Australia. Int J Cancer 112:896–900
Vink J, Crijns MB, Mooy CM, Bergman W, Oosterhuis JA, Went LN (1990) Ocular melanoma in families with dysplastic nevus syndrome. J Am Acad Dermatol 23:858–862
Weinstock MA, Sober AJ (1987). The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 116:303–310
Yu GP, Hu DN, McCormick S, Finger PT (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 135:800–806
Yu GP, Hu DN, McCormick SA (2006) Latitude and incidence of ocular melanoma. Photochem Photobiol 82:1621–1626
Zimmerman LE (1966) Criteria for management of melanosis. Arch Ophthalmol 76:307–308
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Seregard, T., Triay, E. (2008). New Aspects on the Pathogenesis of Conjunctival Melanoma. In: Reinhard, T., Larkin, F. (eds) Cornea and External Eye Disease. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33681-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-33681-5_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33680-8
Online ISBN: 978-3-540-33681-5
eBook Packages: MedicineMedicine (R0)